Approval in severe-to-profound and profound OTOF-related hearing loss is based on pivotal results of the CHORD trial demonstrating 80% of participants achieved or surpassed a hearing level meeting the ...
First Alert 4 on MSN
Some South City residents seek peace and quiet from police shooting range
The St. Louis Police gun range off Gasconade Street along I-55 reopened earlier this year, but without the previous sound ...
US health officials on Thursday greenlit a first-of-its-kind gene therapy to treat a rare form of hereditary hearing loss, a ...
The treatment, developed by Regeneron Pharmaceuticals, is for a very rare form of deafness. But it represents a medical ...
The treatment, the first of its kind, was approved by the Food and Drug Administration on Thursday. “Our baby was born deaf, ...
Otarmeni, now cleared to treat a rare, inherited kind of hearing loss, is the first gene therapy cleared under the FDA’s ...
Travis Smith was a very serious baby. Born completely unable to hear, his mother Sierra struggled to see his personality ...
Approval in severe-to-profound and profound OTOF-related hearing loss is based on pivotal results of the CHORD trial demonstrating 80% of participants achieved or surpassed a hearing level meeting the ...
After months’ worth of rigorous testing, we found four great pairs of open-ear earbuds that sound great while also keeping ...
Gene therapy restores hearing in 90% of patients with OTOF-related deafness, showing lasting improvement and enabling speech development.
"This commission has a responsibility to this neighborhood, and I believe this application, as submitted, fails to honor it," ...
All congenital deafness patients who completed the effective 2.5-year follow-up in a nationwide multicenter clinical study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results